Nuestro producto se presenta en forma de microvesiculas lipdicas en polvo, donde uno o ms principios activos junto con un lpido y un co-lpido forman una dispersin compuesta por partculas lipdicas que encapsulan uno o ms principios activos, finalmente la dispersin se seca formando un polvo que fluye libremente
Worked example 2 the 30 mg vial Concentration: 30 mg 3 mL = 10 mg/mL Starting 2 mg dose: 2 mg 10 mg/mL = 0.20 mL = 20 units At 4 mg: 0.40 mL = 40 units | at 8 mg: 0.80 mL = 80 units | at 12 mg: 1.20 mL = 120 units Notice the higher-strength 30 mg build keeps every draw small the 20 mg, 24 mg and 30 mg vials all reconstitute to the same tidy 10 mg/mL, which is why they are convenient for higher maintenance doses
Vrang N, Hansen M, Larsen PJ, Tang-Christensen M
The Terms of Use publish state-specific medical board complaint contacts for Florida, California, Texas, and Kansas, which suggests the program serves those states - but a complete list covering every state wasn't published